home
portfolio
approach
team
careers
news
contact
investor portal
home
portfolio
approach
team
careers
news
contact
investor portal
Nextech Invest
Revolution Medicines Reports Second Quarter 2024 Financial Results and Update on Corporate Progress
Revolution Medicines Reports Second Quarter 2024 Financial Results and Update on Corporate Progress
Post navigation
Previous Post
Previous
Tango Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Highlights
Next Post
Next
Atavistik Bio Strengthens Leadership Team with Appointment of Paul Bruno, Ph.D. as Chief Business Officer